ArticleJournal of thoracic disease2018

Incidence and risk of thromboembolism associated with bevacizumab in patients with non-small cell lung carcinoma.

Li-Juan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.